Oral Lesions In Non-Celiac Wheat Sensitivity Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

270 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-05-01

Study Completion Date

2020-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Non-celiac gluten sensitivity (NCGS) or 'wheat sensitivity' (NCWS) is included in the spectrum of gluten-related disorders. No data are available on the prevalence of oral lesions in NCWS. Our study aims to evaluate the prevalence of oral lesions in NCWS patients and search for correlations with other clinical characteristics. This prospective observation study will include 90 NCWS patients with irritable bowel syndrome (IBS)- like symptoms, 90 IBS and 90 celiac controls. Patients will be recruited at the Internal Medicine and at the Gastroenterology Units of the University of Palermo. Elimination diet and double-blind placebo controlled (DBPC) wheat challenge proved the NCWS diagnosis. All subjects underwent oral examination to assess the presence or not of oral soft and hard tissue lesions potentially associated to NCWS and CD.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Malnutrition In Non-Celiac Wheat Sensitivity Patients

NCT02421796

Non-Celiac Wheat Sensitivity

COMPLETED

Non-Celiac Wheat Sensitivity: Permanent or Transient Condition?

NCT02823522

Non-Celiac Wheat Sensitivity

RECRUITING

Extraintestinal Non Celiac Wheat Sensitivity

NCT04769180

Non-celiac Gluten Sensitivity

COMPLETED

Diagnostic Significance of Positive EmA Antibodies in the Duodenal Culture Medium of Not-Celiac Wheat Sensitivity (NCWS)

NCT02203201

Not-celiac Gluten Sensitivity

COMPLETED

Autoimmune Diseases and Serum Autoantibodies in NCWS and IBS Patients

NCT04077840

Non-celiac Gluten Sensitivity Non-celiac Wheat Sensitivity

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Celiac disease (CD) has been reported to increase the risk of oral lesions. More recently, it has been reported that a consistent percentage of the general population consider themselves to be suffering from problems caused by wheat and/or gluten ingestion, even though they do not have CD or wheat allergy. This clinical condition has been named Non-Celiac Gluten Sensitivity' (NCGS). In a previous paper the investigators suggested the term 'Non-Celiac Wheat Sensitivity' (NCWS), since it is not known what component of wheat causes the symptoms in NCGS patients, and the investigators also showed that these patients had a high frequency of coexistent multiple food hypersensitivity. That previous study also showed a percentage of NCWS patients had weight loss and anemia: whether these depended on the intestinal malabsorption or not remains unclear. As yet no data are available on the presence and prevalence of oral lesions in NCWS patients. The aims of the present study is: 1) to investigate the presence and prevalence of oral lesions in NCWS patient and 2) to search for a possible correlation between oral lesions and other clinical characteristics of NCWS patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Non-celiac Wheat Sensitivity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

NCWS patients

Consecutive adult patients with an irritable bowel syndrome (IBS)-like clinical presentation, according to Rome II criteria, and a definitive diagnosis of NCWS.

No interventions assigned to this group

CD patients

Sex- and age-matched subjects with CD, diagnosed according to standard criteria during the same study period and enrolled as first control group.

No interventions assigned to this group

IBS patients

Sex- and age-matched subjects with IBS unrelated to NCWS or other food 'intolerance', diagnosed according to standard criteria during the same study period and enrolled as second control group.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

To diagnose NCWS the recently proposed criteria will be adopted. All the patients will meet the following criteria:

* negative serum anti-transglutaminase (anti-tTG) and anti-endomysium (EmA) immunoglobulin (Ig)A and IgG antibodies;
* absence of intestinal villous atrophy;
* negative IgE-mediated immune-allergy tests to wheat (skin prick tests and/or serum specific IgE detection);
* resolution of the IBS symptoms on standard elimination diet, excluding wheat, cow's milk, egg, tomato, chocolate, and other self-reported food(s) causing symptoms;
* symptom reappearance on double-blind placebo-controlled (DBPC) wheat challenge. As the investigators previously described in other studies, DBPC cow's milk protein challenge and other "open" food challenges will be performed too.

* age \>18 years; follow-up duration longer than six months after the initial diagnosis;
* at least two outpatient visits during the follow-up period.

Exclusion Criteria

* positive EmA in the culture medium of the duodenal biopsies, also in the case of normal villi/crypts ratio in the duodenal mucosa;
* self-exclusion of wheat from the diet and refusal to reintroduce it, before entering the study;
* other "organic" gastrointestinal disorders;
* nervous system disease and/or major psychiatric disorder;
* physical impairment limiting physical activity;
* menopause;
* steroid and sex steroid therapy, hormone replacement therapy or ovariectomy.

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No